(Q36914893)

17 August 2017

Clinical progression rates by CD4 cell category before and after the initiation of combination antiretroviral therapy (cART). (English)

1 reference

17 August 2017

anti-retroviral agent

0 references

author

Dominique Costagliola

4

object named as

Dominique Costagliola

0 references

Andrew N Phillips

3

object named as

Andrew Phillips

1 reference

17 August 2017

Marguerite Guiguet

1

1 reference

17 August 2017

Kholoud Porter

2

1 reference

17 August 2017

Abdel Babiker

5

1 reference

17 August 2017

12 February 2008

1 reference

17 August 2017

The open AIDS journal

1 reference

17 August 2017

2

1 reference

17 August 2017

3-9

1 reference

When should antiretroviral therapy for HIV be started?

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556203

CD4+ count-guided interruption of antiretroviral treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556203

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556203

Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556203

Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556203

Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556203

Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556203

AIDS events among individuals initiating HAART: do some patients experience a greater benefit from HAART than others?

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18923700

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment response

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18923700

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18923700

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2174/1874613600802010003

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

18923700

1 reference